Customer Services
Sealand Enterprises Ltd.17/F, Tai Yip Building,
141 Thomson Road, Wachai, Hong Kong
Tel (852) 2512 1086
Fax (852) 2512 1609
Email：
info@sealand-hk.com
上海市第一中級人民法院5月21日判決 |
Coriolus Versicolor PSP
Coriolus Versicolor PSP
- Coriolus Versicolor PSP was invented by a Shanghai Normal University expert team led by Professor Q.Y. Yang in 1982, and the corresponding patent was granted to Shanghai Normal University in 1989. With the approval of the Ministry of Health, and later the State Food and Drugs Administration Bureau, Shanghai Xinkang Pharmaceutical Factory has been the authorized sole manufacturer of the patented Coriolus Versicolor PSP.
- PSP stands for Polysaccharide Peptide, a protein-bound polysaccharide extracted from deep-layer-cultivated mycelia of the COV-1 strain of Coriolus Versicolor, commonly known as Yunzhi.
Coriolus Versicolor PSP
- Enhances body immunity, complements radiotherapy and chemotherapy treatments of cancer patients, effectively improves treatment results, and alleviates the side effects
- Improves appetite, sleeping quality, and patients’ overall quality of life
- A product that has gone through stringent clinical trials, and it has been extensively researched and wrote about by researchers, pharmacologists, oncologists of the Chinese mainland, Hong Kong University, Hong Kong Chinese University, Hong Kong Polytechnic University, the US, UK, Korea, Japan, etc. Three international conferences were specially convened on PSP in 1993, 1989 & 1999 in Hong Kong
- It is a pure natural extract of Coriolus Versicolor (commonly known as Yunzhi). Since it was available in the market 20 years ago, over a million patients have used PSP and benefited from it – a sound record of proven efficacy and free of any side effect. It is the most mature product of its kind in the market.
PSP History
- 70s
Japanese scientists were the first who did research on Coriolus Versicolor employing modern technology, and successfully extracted a polysaccharide (PSK) from the COV-1 strain. PSK is patented and proven that it can effectively enhance immunity of human body. - Early 80s
An expert team led by Prof. Q.Y. Yang of Shanghai Normal University conducted extensive research on nearly 100 strains of Coriolus versicolor, identified and extracted a polysaccharide petide (PSP) from the deep cultivated mycelium of COV-1 strain. Scientific tests showed that the effectiveness of PSP was even better than PSK, which was then a popular medicine in Japan for treatment of cancer patients. When news hit the street, PSP immediately gained interntional attention. - 1987-89
The patent on PSP was granted to the Shanghai Normal University. (Patent No: 89105471) - 1989
The first “PSP” international conference was convened in Hong Kong. - 1991-92
Stage I, II and III double-blind randomized placebo-controlled clinical trials were conducted through 24 specialist hospitals with more than 1,100 cancer patients in major cities in China. The clinical trials proved the efficacy of using PSP in complementing radiotherapy and chemical treatments of patients suffering from various type of cancer; and the subsequent registration of “Coriolus versicolor PSP” as a new medicine was approved by Ministry of Health in China. In the same year, Shanghai Normal University established Shanghai XinKang Pharmaceutical Factory, with which exclusively used the patent right and manufactured the medicine “Coriolus versicolor PSP”. - 1990 -2005
Shanghai Normal University and Winsor Pharmaceutical Co. of Hong Kong came into an exclusive distributorship agreement in supplying “Coriolus versicolor PSP” to Winsor Pharmaceutical and its associate companies for their products “Yunzhi Essence” and “I’m Yunity Yunzhi Essence”. The terms lasted 15 years from 1990 to 2005. - 1992
“Coriolus versicolor PSP” has been extensively researched and written about by experts and researchers of the University of Hong Kong, Chinese University of Hong Kong , Polytechnic University of Hong Kong, major universities on mainland China, Taiwan, the US, UK, Japan, S. Korea, New Zealand, and Taiwan. The US National Library of Medicine has collected about 200 “Coriolus versicolor PSP” related clinical reports and research papers. - 1993
The second “Coriolus versicolor PSP” international conference was convened in Hong Kong. - 1999
The third “Coriolus versicolor PSP” international conference, titled “Advanced Research in PSP” was convened in Hong Kong. In the same year, a double-blind randomized placebo-controlled clinical trial was conducted by University of Hong Kong in Queen Mary Hospital using PSP to complement radiotherapy and chemotherapy treatment of patients suffering from lung cancer. The results again proved the efficacy of “Coriolus versicolor PSP”. - 2006
Shanghai Normal University stopped supplying “Coriolus versicolor PSP” to Windsor Pharmaceutical Co. and its associated companies in Hong Kong for their products “Yunzhi Essence” and “I’m Yunity Yunzhi Essence”; and established Sealand Enterprises Ltd. In Hong Kong as the new sole overseas distributor of “Coriolus versicolor PSP”. The product is sold exclusively in the original brand name “Qing Kang”.
